Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale

Saved in:
Bibliographic Details
Title: Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale
Language: English
Authors: Johnco, Carly J., De Nadai, Alessandro S., Lewin, Adam B.
Source: Journal of Autism and Developmental Disorders. Oct 2015 45(10):3232-3242.
Availability: Springer. 233 Spring Street, New York, NY 10013. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-348-4505; e-mail: service-ny@springer.com; Web site: http://www.springerlink.com
Peer Reviewed: Y
Page Count: 11
Publication Date: 2015
Document Type: Journal Articles
Reports - Research
Descriptors: Anxiety Disorders, Pervasive Developmental Disorders, Autism, Cognitive Restructuring, Behavior Modification, Therapy, Rating Scales, Symptoms (Individual Disorders), Scores, Evaluation Criteria, Pediatrics, Guidelines, Comorbidity, Children, Adolescents, Cutting Scores, Measures (Individuals), Outcomes of Treatment
DOI: 10.1007/s10803-015-2483-9
ISSN: 0162-3257
Abstract: This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7-16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15% reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40% reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.
Abstractor: As Provided
Number of References: 42
Entry Date: 2015
Accession Number: EJ1074351
Database: ERIC
Description
Abstract:This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7-16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15% reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40% reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.
ISSN:0162-3257
DOI:10.1007/s10803-015-2483-9